Skip to main content

Ethical Issues in Studying the Safety of Approved Drugs: A Letter Report

View Cover

Overview

Contributors

Description

The FDA requested that the IOM examine the ethical and informed consent issues that should be considered when conducting clinical trials to evaluate drug safety. This report outlines when and how the FDA should conduct clinical trials to protect the public's health and the health of trial participants.

Topics

Suggested Citation

Institute of Medicine. 2010. Ethical Issues in Studying the Safety of Approved Drugs: A Letter Report. Washington, DC: The National Academies Press. https://doi.org/10.17226/12948.

Import this citation to:

Publication Info

25 pages | 8.5 x 11
DOI: https://doi.org/10.17226/12948
Contents

Table of Contents

skim chapter
Front Matter i-x
Letter Report 1-15
Resources
Rights

Copyright Information

The National Academies Press and the Transportation Research Board have partnered with Copyright Clearance Center to offer a variety of options for reusing our content. You may request permission to:

  • Republish or display in another publication, presentation, or other media
  • Use in print or electronic course materials and dissertations
  • Share electronically via secure intranet or extranet
  • And more

For most Academic and Educational uses no royalties will be charged although you are required to obtain a license and comply with the license terms and conditions.

Click here to obtain permission for Ethical Issues in Studying the Safety of Approved Drugs: A Letter Report.

Translation and Other Rights

For information on how to request permission to translate our work and for any other rights related query please click here.

Copyright.com Customer Service

For questions about using the Copyright.com service, please contact:

Copyright Clearance Center
22 Rosewood Drive
Danvers, MA 01923
Tel (toll free): 855/239-3415 (select option 1)
E-mail: info@copyright.com
Web: https://www.copyright.com
Stats

Loading stats for Ethical Issues in Studying the Safety of Approved Drugs: A Letter Report...